Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P106. Active macrophage migration inhibitory factor (MIF) is a previously unrecognized isoform of MIF and a potential new biomarker for inflammatory bowel diseases
Authors:

D. Völkel1, M. Thiele1, P. Douillard1, R. Kerschbaumer1, F. Scheiflinger1, H. Ehrlich1, H. Tilg2, A. Moschen2, 1Baxter Innovations GmbH, Vienna, Austria, 2Medical University Innsbruck, Department of Medicine, Innsbruck, Austria

P106. Faecal calprotectin: Useful for clinical differentiation of microscopic colitis and irritable bowel syndrome?
P106. Health related quality of life and work productivity in Greek patients with inflammatory bowel disease [Hellenic IBD study group]
P106

Screening for melanoma and non melanoma skin cancer in IBD patients before and after thiopurines and anti-TNFs: A single-center prospective cohort study

Authors:

E. Lolli*1, R. Saraceno2, E. Calabrese1, M. Ascolani1, C. Petruzziello1, P. Scarozza1, A. Ruffa1, S. Onali1, S. Chimenti2, F. Pallone1, L. Biancone1

1Università di Roma Tor Vergata, Medicina dei sistemi, cattedra di Gastroenterologia, Roma, Italy, 2Università degli Studi di Roma "Tor Vergata", Medicina dei Sistemi, Rome, Italy

P107.

Usefulness of a rapid test for fecal calprotectin as predictor of relapse in Crohn's disease patients under maintenance treatment with adalimumab

Authors:

R. Ferreiro, M. Barreiro-de Acosta, A. Lorenzo, J.E. Dominguez-Muñoz, University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain

P107. A budget impact model to evaluate medication persistence and associated healthcare costs
P107. Action of leukocytapheresis is associated with calcitonin gene-related peptide induction in colitis models
Authors:

H. Yamasaki1, K. Mitsuyama1, H. Takedatsu1, T. Kobayashi1, K. Kuwaki1, K. Nagayama1, S. Yoshioka1, O. Tsuruta1, M. Sata1, 1Kurume University School of Medicine, Division of Gastroenterology, Department of Medicine, Kurume, Japan

P107. Serological markers can predict inflammatory bowel disease years before the diagnosis: Results from a nested case–control study within a European cohort study
P107

Increased prevalence of lower GI tract abnormalities without any IBD in patients with primary biliary cirrhosis

Authors:

M. Basaranoglu*1, 2, M. Yuksel3, O. Coskun3, M. Kaplan2, A. Aksoy2, Z. Bilge2, N. Turhan4, M. Ozdemir5

1Bezmialem University, Gastroenterology, Istanbul, Turkey, 2Türkiye Yuksek Ihtisas Hospital, Gastroenterology, Ankara, Turkey, 3Türkiye Yüksek Ihtisas, Gastroenterology, Ankara, Turkey, 4Türkiye Yuksek Ihtisas Hospital, Pathology, Ankara, Turkey, 5Türkiye Yuksek Ihtisas Hospital, Radiology, Ankara, Turkey

P108.

Towards patient-reported disease severity index in inflammatory bowel disease

Authors:

L. Alrubaiy1,2, J. Williams1, H. Hutchings1, 1Swansea University, College of Medicine, Swansea, United Kingdom, 2Royal Gwent Hospital, Gastroenterology, Newport, United Kingdom

P108. FAM5C, a possible causal molecule in ulcerative colitis revealed through a transcriptomic analysis of the bowel mucosa
Authors:

P.J. Smith1, A.P. Levine1, G.W. Sewell1, N.R. O'Shea1, M. Rodriguez-Justo2, M. Novelli2, R. Vega3, S.L. Bloom3, A.M. Smith1, A.W. Segal1, 1University College London, Division of Medicine, London, United Kingdom, 2University College London Hospitals NHS Foundation Trust, Department of Histopathology, London, United Kingdom, 3University College London Hospitals NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom

P108. Fistulizing pattern is associated with a higher frequency and incidence of cancer in Crohn's disease: A single-center cohort study involving 1288 patients with inflammatory bowel disease
P108. Is early surgery associated with a more benign disease course in Crohn's disease? Surgery rates in a population-based inception cohort from Western Hungary between 1977–2009
P108

Mean Platelet Volume As An Inflammatory Marker In Inflammatory Bowel Disease

Authors:

Y. Alahdab*1, K. Abacar2, G. Karakaya2, A. Ozdemir2

1Fatih Sultan Mehmet Egitim Arastirma Hastanesi, Gastroenterology, Istanbul, Turkey, 2Fatih Sultan Mehmet Egitim Arastirma Hastanesi, Internal Medicine, Istanbul, Turkey

P109.

Thiopurines and anti-TNFs after a diagnosis of cancer in patients with inflammatory bowel disease

Authors:

S. Onali, C. Petruzziello, G. Condino, M. Ascolani, E. Calabrese, E. Lolli, A. Ruffa, F. Pallone, L. Biancone, Università di Roma Tor Vergata, Medicina dei sistemi, cattedra di Gastroenterologia, Roma, Italy

P109. Diagnostic value of magnetic resonance enterography compared with capsule endoscopy in small-bowel mucosal lesions in patients with suspected or established non-obstructive Crohn's disease: A meta-analysis
P109. Evolution of the disease behavior in pediatric and adult onset CD in a population-based incident cohort from Western Hungary
P109. Use of faecal calprotectin as predictor of relapse in patients under maintenance treatment with infliximab
Authors:

R. Ferreiro1, M. Barreiro-de Acosta1, M. Otero2, A. Lorenzo1, C. Alonso2, J.E. Dominguez-Munoz1, 1University Hospital, Gastroenterology, Santiago, Spain, 2Department of Laboratory Medicine, Santiago, Spain

P109

The prevalence of liver, biliary tract and pancreas abnormalities in patients with Inflammatory Bowel Disease screened by US and confimed by echoendoscopy

Authors:

M. Basaranoglu*1, 2, M. Yuksel3, O. Coskun3, M. Kaplan2, M. Ozdemir4, N. Turhan5, A. Aksoy2

1Bezmialem University, Gastroenterology, Istanbul, Turkey, 2Türkiye Yuksek Ihtisas Hospital, Gastroenterology, Ankara, Turkey, 3Türkiye Yüksek Ihtisas, Gastroenterology, Ankara, Turkey, 4Türkiye Yuksek Ihtisas Hospital, Radiology, Ankara, Turkey, 5Türkiye Yuksek Ihtisas Hospital, Pathology, Ankara, Turkey

P110.

The use of the Pediatric Ulcerative Colitis Activity Index (PUCAI) in adults with acute severe ulcerative colitis (ASC)

Authors:

B. Koslowsky1, A. Gupta2, D.M. Livovsky1, T. Adar1, D. Turner3, F. Hartnell4, C. Praticò5, S. Travis6, 1Shaare Zedek Medical Center, Gastroenterology, Jerusalem, Israel, 2The Canberra Hospital, Gastroenterology, Woden, Australian Capital Territory, Australia, 3Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Pediatric Gastroenterology, Jerusalem, Israel, 4Royal Brisbane and Women's Hospital, Gastroenterology, Brisbane, Queensland, Australia, 5University of Bologna, Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Bologna, Italy, 6Oxford University Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom